P73S (p.Pro73Ser) variant of SGCA (Alpha-sarcoglycan)

P73S (p.Pro73Ser) in SGCA (Alpha-sarcoglycan) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Autosomal recessive limb-girdle muscular dystrophy type 2D. The available variant effect predictions contribute to a CATVariant prioritization score of 0.87 / 1. The record also includes population frequency data and structural context.

P73S (p.Pro73Ser) variant details